Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Google Scholar citation report
Citations : 2975
Journal of Clinical & Experimental Pathology received 2975 citations as per Google Scholar report
Journal of Clinical & Experimental Pathology peer review process verified at publons
Indexed In
- Index Copernicus
- Google Scholar
- Sherpa Romeo
- Open J Gate
- Genamics JournalSeek
- JournalTOCs
- Cosmos IF
- Ulrich's Periodicals Directory
- RefSeek
- Directory of Research Journal Indexing (DRJI)
- Hamdard University
- EBSCO A-Z
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- ICMJE
- world cat
- journal seek genamics
- j-gate
- esji (eurasian scientific journal index)
Useful Links
Recommended Journals
Related Subjects
Share This Page
Evaluation of human epidermal growth factor receptor (HER-2/neu) in gastric adenocarcinoma: A study from South Asia region
12th International Conference on Pediatric Pathology & Laboratory Medicine
Asma Shabbir, Muhammad Asif Qureshi, Talat Mirza and Abdullah Bin Khalid
Jinnah Sindh Medical University, Pakistan
ScientificTracks Abstracts: J Clin Exp Pathol
Abstract
Background & Aim: Gastric cancer is the third leading cause of cancer mortality worldwide. Human epidermal growth factor (HER- 2/neu) has shown strong therapeutic implication in breast cancer. Expression of HER-2/neu in gastric cancer has been reported from across the world, it is still unknown from South Asia region. The aim of this study is to evaluate HER-2/neu expression in gastric adenocarcinomas and to correlate with various clinicopathological variables. Patients & Method: A total of 95 consecutive patients undergoing endoscopic biopsy or gastrectomy were recruited in this study after institutional ethical approval. Clinicopathological parameters of all patients were recorded and hematoxylin and eosin (H&E) staining was performed. Expression of HER-2/neu was investigated by immunohistochemistry using �±-HER-2 antibody. Hofmann validation scoring system was used and its association was seen with various clinicopathological variables including age, gender, histopathological type, grade and stage of the tumor. Results: HER-2/neu over expression was found in 21 (22.1%) cases from the total of 95 gastric adenocarcinomas. HER-2/neu was significantly expressed in low grade gastric cancer (p=0.030). Although there was no significant difference between HER-2/neu expression and other variables, HER-2/neu score 3+ was higher in females, age >60 years, Laurens intestinal type and IIIC stage. Conclusion: HER-2/neu is expressed in a limited group of gastric cancer patients in Pakistani population. Our findings indicate a significant strong association of HER-2/neu expression with low grades of gastric cancer.Biography
Asma Shabbir has done her MBBS from B J Medical College, Pune, India. She has done her Post-graduation from Dow International Medical College, Karachi, Pakistan. She has a passion towards research and concerned for better prognosis of the patient. She has presented her research work in many conferences. Recently, she received the Young Researcher Award at the International Conference of Digestive Diseases in Dubai 2016. She is a member of different scientific and research associations. At present, she is working as a Researcher and as an Assistant Professor in the Department of Pathology, Jinnah Sindh Medical University, Pakistan.
Email: drasma52@gmail.com
